Growth Metrics

Beneficient (BENF) EPS (Weighted Average and Diluted) (2021 - 2025)

Beneficient's EPS (Weighted Average and Diluted) history spans 5 years, with the latest figure at $0.04 for Q4 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) rose 100.49% to $0.04 in Q4 2025 year-over-year; TTM through Dec 2025 was -$8.4, a 91.04% increase, with the full-year FY2025 number at $0.06, up 100.01% from a year prior.
  • EPS (Weighted Average and Diluted) hit $0.04 in Q4 2025 for Beneficient, up from -$0.37 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for BENF hit a ceiling of $0.17 in Q2 2024 and a floor of -$426.61 in Q2 2023.
  • Historically, EPS (Weighted Average and Diluted) has averaged -$57.4 across 5 years, with a median of -$0.62 in 2025.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): crashed 386400.0% in 2023 and later surged 100.49% in 2025.
  • Tracing BENF's EPS (Weighted Average and Diluted) over 5 years: stood at -$0.14 in 2021, then surged by 78.57% to -$0.03 in 2022, then plummeted by 527766.67% to -$158.36 in 2023, then skyrocketed by 94.85% to -$8.16 in 2024, then surged by 100.49% to $0.04 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for BENF at $0.04 in Q4 2025, -$0.37 in Q3 2025, and -$7.19 in Q2 2025.